Arch Therapeutics prices $2.8M registered direct offering

|About: Arch Therapeutics, Inc. (ARTH)|By:, SA News Editor

Arch Therapeutics (OTCQB:ARTH) has priced its registered direct offering of ~8.6M units for gross proceeds of ~$2.8M.

Each unit consists of a Common Share, and a Series H Warrant to purchase one common share for the combined price of $0.325 per unit.

The Series H Warrants have an exercise price of $0.40 per share and are exercisable for a period of five years.

Closing date is May 14.

Subscribe for full text news in your inbox